M. Ashfaq-khan

Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver disease

D. Schuppan, S. Strand, J. Schattenberg, 2019, Scientific Reports.

Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.

D. Schuppan, S. Wirtz, R. Surabattula, 2020, Gastroenterology.

Preparation and characterization of anticancer niosomal withaferin–A formulation for improved delivery to cancer cells: In vitro, in vivo, and in silico evaluation

Zaheer Ul-Haq, Ruqaiya Khalil, A. Mushtaq, 2020, Journal of Drug Delivery Science and Technology.

Non-celiac wheat sensitivity: differential diagnosis, triggers and implications.

D. Schuppan, G. Pickert, V. Zevallos, 2015, Best practice & research. Clinical gastroenterology.

Liver fibrosis: Direct antifibrotic agents and targeted therapies.

D. Schuppan, Yong Ook Kim, M. Ashfaq-khan, 2018, Matrix biology : journal of the International Society for Matrix Biology.

Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells.

D. Schuppan, S. Tenzer, H. Schild, 2017, Gastroenterology.

Rapamycin and zoledronic acid synergistically repolarize tumour associated macrophages towards anti-HCC responses

D. Schuppan, R. Surabattula, Yong Ook Kim, 2017 .

Characterization of the cancer immune microenvironment of Mdr2(abcb4)-/- mice treated with diethylnitrosamine – a novel model close to human hepatocarcinogenesis

D. Schuppan, Yong Ook Kim, T. Zimmermann, 2017 .